Volume XXIV No. 12 – August 28, 2017
Table of Contents
Articles
50,000 Patients to Retest After Invitae Finds Errors
Estimating Total Costs When Genetic Tests Must Be Retested
Invitae Investing Heavily To Expand Market Share
Two Largest Payers Start Lab Test Pre-Authorization
UnitedHealth to Start Gene Test Pre-Approval
Anthem/AIM Responds to Queries About Its Pre-Approval Program
Labs Report Problems with Anthem’s Pre-Approval
Intelligence
Commentary & Opinion by R. Lewis Dark